GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Gold stocks outperform equities surge
May 11, 2026 / www.canadianminingreport.com
Global tech once again leading the markets in 2026
May 11, 2026 / www.canadianminingreport.com
Strong Q1/26 results continue with Agnico, Kinross and Alamos reporting
May 04, 2026 / www.canadianminingreport.com
Gold stocks decline as equities reach all-time highs
May 04, 2026 / www.canadianminingreport.com
Gold stocks decline on metal pullback
April 27, 2026 / www.canadianminingreport.com